Urological Survey UROLOGICAL ONCOLOGY: RENAL, URETERAL AND RETROPERITONEAL TUMORS Quantitative Detection of Promoter Hypermethylation of Multiple Genes in the Tumor, Urine, and Serum DNA of Patients With Renal Cancer

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients.

  2003cited by this paper

• Surface-enhanced Raman spectroscopy for the characterization of different anatomical subtypes of oral cavity cancer.

  2023cites this paper
• Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting

  2023cites this paper
• Significance of promoter methylation of multiple tumor suppressor genes in hepatocellular carcinoma

  2022cites this paper
• Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma

  2022cites this paper
• LiKidMiRs: A ddPCR-Based Panel of 4 Circulating miRNAs for Detection of Renal Cell Carcinoma

  2022cites this paper
• Epigenetics in advanced renal cell carcinoma: potential new targets.

  2022cites this paper
• Circulating Cell-Free DNA in Renal Cell Carcinoma: The New Era of Precision Medicine

  2022influential citation
• Pathogen-Induced Epigenetic Modifications in Cancers: Implications for Prevention, Detection and Treatment of Cancers in Africa

  2021cites this paper
• SOX17 Antagonizes the WNT Signaling Pathway and is Epigenetically Inactivated in Clear-Cell Renal Cell Carcinoma

  2021cites this paper
• Promoter Hypermethylation of LATS1 Gene in Oral Squamous Cell Carcinoma (OSCC) among North Indian Population

  2021cites this paper
• Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies

  2021cites this paper
• Targeting Epigenetic Regulators for Endometrial Cancer Therapy: Its Molecular Biology and Potential Clinical Applications

  2021cites this paper
• The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments

  2021cites this paper
• Epigenetic Biomarkers of Renal Cell Carcinoma for Liquid Biopsy Tests

  2021influential citation
• Clinical significance of novel DNA methylation biomarkers for renal clear cell carcinoma

  2021cites this paper
• Association of APC gene promoter methylation and the risk of gastric cancer

  2020cites this paper
• Prospects for incorporation of epigenetic biomarkers in human health and environmental risk assessment of chemicals

  2020cites this paper
• Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer

  2020cites this paper
• Epigenetic Dysregulation in Advanced Kidney Cancer

  2020cites this paper
• Diagnostic DNA Methylation Biomarkers for Renal Cell Carcinoma: A Systematic Review.

  2019cites this paper
• Plasma Epstein–Barr virus DNA as an archetypal circulating tumour DNA marker

  2019cites this paper
• Highly sensitive detection of DNA hypermethylation in melanoma cancer cells.

  2019cites this paper
• Epidemiology, Screening, and Clinical Staging

  2019cites this paper
• DNA-Methylation-Based Detection of Urological Cancer in Urine: Overview of Biomarkers and Considerations on Biomarker Design, Source of DNA, and Detection Technologies

  2019influential citation
• Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study.

  2018cites this paper
• Epigenetics in renal cell cancer: mechanisms and clinical applications

  2018cites this paper
• Targeting DNA Methyltranferases in Urological Tumors

  2018cites this paper
• Urinary cell-free nucleic acid IQGAP3: a new non-invasive diagnostic marker for bladder cancer

  2018cites this paper
• Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview

  2018cites this paper
• Microfluidics for minute DNA sample analysis: open challenges for genetic testing of cell-free circulating DNA in blood plasma

  2018cites this paper
• Modification of the association between recreational physical activity and survival after breast cancer by promoter methylation in breast cancer-related genes

  2017cites this paper
• The G-BHQ synergistic effect: Improved double quenching molecular beacons based on guanine and Black Hole Quencher for sensitive simultaneous detection of two DNAs.

  2017cites this paper
• METHYLATION OF GAL3 PROMOTER FOR EARLY DAGNOSIS OF PROSTATE CANCER

  2017cites this paper
• TIMP3 promoter hypermethylation contributes to the risk of renal cell carcinoma: A meta-analysis

  2017influential citation
• Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel

  2017cites this paper
• A Review of Salivary Biomarker: A Tool for Early Oral Cancer Diagnosis

  2017cites this paper
• Promoter methylation of tumor-related genes as a potential biomarker using blood samples for gastric cancer detection

  2017cites this paper
• Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer

  2016cites this paper
• Clinical potential of TCF21 methylation in the diagnosis of renal cell carcinoma

  2016cites this paper
• ПРОФИЛИ ЭКСПРЕССИИ И МЕТИЛИРОВАНИЯ ГЕНОВ ПРИ СВЕТЛОКЛЕТОЧНОЙ КАРЦИНОМЕ ПОЧКИ

  2016cites this paper
• Epigenetic Biomarkers of Disease

  2016cites this paper
• Serum biomarkers for detection of head and neck squamous cell carcinoma

  2016cites this paper
• Phase II Trial of Target-guided Personalized Chemotherapy in First-line Metastatic Colorectal Cancer

  2016cites this paper
• Prediction efficiency of PITX2 DNA methylation for prostate cancer survival.

  2016cites this paper
• Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms.

  2016cites this paper
• A comparative analysis of methylation status of tumor suppressor genes in paired biopsy and serum samples from cervical cancer patients among north indian population

  2016cites this paper
• Robust Detection of DNA Hypermethylation of ZNF154 as a Pan-Cancer Locus with in Silico Modeling for Blood-Based Diagnostic Development.

  2016cites this paper
• Aberrant methylation of APC and RARβ2 genes in breast cancer patients

  2015cites this paper
• Epigenetic biomarkers in the blood of patients with urological malignancies

  2015cites this paper
• Epigenetic silencing of S100A2 in bladder and head and neck cancers

  2015cites this paper
• Frequent Epigenetic Suppression of Tumor Suppressor Gene Glutathione Peroxidase 3 by Promoter Hypermethylation and Its Clinical Implication in Clear Cell Renal Cell Carcinoma

  2015cites this paper
• Epigenetic inactivation of the candidate tumor suppressor gene ASC/TMS1 in human renal cell carcinoma and its role as a potential therapeutic target

  2015cites this paper
• Diagnostic and prognostic epigenetic biomarkers in cancer.

  2015cites this paper
• The Role of Epigenomics in the Study of Cancer Biomarkers and in the Development of Diagnostic Tools.

  2015cites this paper
• Detecting abnormal methylation of tumor suppressor genes GSTP1, P16, RIZ1, and RASSF1A in hepatocellular carcinoma and its clinical significance.

  2015cites this paper
• ST 1 R methylation as a diagnostic biomarker in renal ell tumors na

  2015cites this paper
• Aberrant Methylation of RASSF1A gene Contribute to the Risk of Renal Cell Carcinoma: a Meta-Analysis.

  2015cites this paper
• Aberrant methylation of the TERT promoter in esophageal squamous cell carcinoma.

  2015cites this paper
• Safeguarding genome stability: RASSF1A tumor suppressor regulates BRCA2 at stalled forks

  2015cites this paper
• MST1R methylation as a diagnostic biomarker in renal cell tumors

  2015cites this paper
• Methylated DNA for monitoring tumor growth and regression: How do we get there?

  2014cites this paper
• DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.

  2014cites this paper
• MGMT promoter methylation in plasma of glioma patients receiving temozolomide

  2014cites this paper
• Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential

  2014cites this paper
• Demethylation of RARβ2 gene promoter by Withania somnifera in HeLa cell line.

  2014cites this paper
• Neuroendocrine Tumor Biomarkers: Current Status and Perspectives

  2014cites this paper
• Retinoids: Nutritional, Cellular, and Pharmacological Roles of the Vitamin A Derivatives

  2014cites this paper
• Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies

  2014cites this paper
• Epigenetic Alterations of Chromosome 3 Revealed by NotI-Microarrays in Clear Cell Renal Cell Carcinoma

  2014cites this paper
• Epigenetic Silencing of DAPK1 Gene is Associated with Faster Disease Progression in India Populations with Chronic Myeloid Leukemia

  2013cites this paper
• Epigenetics and MicroRNAs in Renal Cancer

  2013cites this paper
• Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients.

  2013cites this paper
• Genome-Wide Promoter Methylome of Small Renal Masses

  2013cites this paper
• HPV and methylation indicators in paired tumor and saliva in HNSCC

  2013cites this paper
• Raman spectroscopy of serum: an exploratory study for detection of oral cancers.

  2013cites this paper
• Methylation profiling and evaluation of demethylating therapy in renal cell carcinoma

  2013cites this paper
• Methylated DNA and microRNA in Body Fluids as Biomarkers for Cancer Detection

  2013cites this paper
• Translational genomics: the challenge of developing cancer biomarkers.

  2012cites this paper
• Epigenetic biomarkers in cancer epidemiology.

  2012cites this paper
• Prognostic and diagnostic relevance of hypermethylated in cancer 1 (HIC1) CpG island methylation in renal cell carcinoma.

  2012cites this paper
• Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis.

  2012cites this paper
• For Peer Review Prognostic Significance of TIMP3 Hypermethylation in Post- treatment Salivary Rinse from Head and Neck Squamous Cell Carcinoma Patients

  2012cites this paper
• p16 gene methylation in colorectal cancer patients with long-term follow-up.

  2012cites this paper
• p 16 gene methylation in colorectal cancer patients with long-term follow-up

  2012cites this paper
• Wnt signaling pathways in urological cancers: past decades and still growing

  2012cites this paper
• ЛОКАЛИЗАЦИЯ ТОЧКОВЫХ МУТАЦИЙ В КОДИРУЮЩЕЙ ЧАСТИ ГЕНА VHL ПРИ СВЕТЛОКЛЕТОЧНОМ РАКЕ ПОЧКИ

  2012cites this paper
• Genetic and Epigenetic Biomarkers in Cancer

  2012cites this paper
• Identification of Cellular Proteins Required for Replication of Human Immunodeficiency Virus Type 1

  2012cites this paper
• Investigating the dual roles of STRA6 in cell signaling and vitamin A trafficking

  2012cites this paper
• Malignant Renal Tumors

  2012cites this paper
• Multi-level Whole Genome Analysis Reveals Candidate Biomarkers in Clear Cell Renal Cell Carcinoma

  2012cites this paper
• Plasma DNA methylation of Wnt antagonists predicts recurrence of esophageal squamous cell carcinoma.

  2011cites this paper
• DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminoma

  2011cites this paper
• Epigenetics of kidney cancer and bladder cancer.

  2011cites this paper
• TCF21 and PCDH17 methylation: An innovative panel of biomarkers for a simultaneous detection of urological cancers

  2011cites this paper
• LINE-1 Methylation Levels in Leukocyte DNA and Risk of Renal Cell Cancer

  2011cites this paper
• Can a simple proteomics urine test assist in the early diagnosis of early-stage cancer?

  2011cites this paper
• Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine Sediments

  2011cites this paper
• Epigenetic diagnostics of cancer — the application of DNA methylation markers

  2010cites this paper
• Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease

  2010cites this paper